"Anigen," Reassessed as a New Drug Development Company, Shows Steep Uptrend!

On the 12th, pharmaceutical manufacturer "Anygen" saw its stock price surge due to the potential for future technology transfer and clinical entry.

▶ Experience and decide by directly composing a customized analysis portfolio! Apply for YC Investment Group's free trial

On this day, the securities industry analyzed and forecasted Anygen, which holds the only peptide Good Manufacturing Practice (GMP) factory in Korea, showing continuous sales growth through its contract manufacturing business.

Then, what if securities firms had accessed highly analytical data that predicted market trends in advance? The problem for individual investors is that once they latch onto information, they tend to move forward blindly.

▶ Are you currently holding uncertain investment information? You must verify, doubt, and verify again.

Investment information differs sharply in terms of verifiability. It is difficult for individuals to carry out the perfect process of verifying and re-verifying that verifiability.

Why do professional investment analysts with advanced analytical skills exist? It is precisely for this reason. What if you now have perfect investment information data generated by combining artificial intelligence big data systems that overcome human limitations?

This reliable weapon will paint your account red and make your dreams come true.

▶ Establish a perfect investment strategy with investment analysts with over 14 years of experience and artificial intelligence big data!

Stocks of interest: EcoPro HN / EcoPro / ChemTros / HUSUNG / Huchems

※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.